Antipsychotic drug prescription rates among Dutch nursing homes: the influence of patient characteristics and the dementia special care unit

References

• Ballard, C., Hanney, M.L., Theodoulou, M., Douglas, S., McShane, R., Kossakowski, K., … Jacoby, R. (2009a). The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial. Lancet Neurology, 8, 151–157.
   PubMed Web of Science ®Google Scholar
• Ballard, C.G., Gauthier, S., Cummings, J.L., Brodaty, H., Grossberg, G.T., Robert, P., & Lyketsos, C.G. (2009b). Management of agitation and aggression associated with Alzheimer disease. Nature Reviews Neurology, 5, 245–255.
   PubMed Web of Science ®Google Scholar
• Ballard, C.G., & Margallo-Lana, M.L. (2004). The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities. The Journal of Clinical Psychiatry, 65, 23–28.
   PubMed Web of Science ®Google Scholar
• Briesacher, B.A., Limcangco, M.R., Simoni-Wastila, L., Doshi, J.A., Levens, S.R., Shea, D.G., & Stuart, B. (2005). The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine, 165, 1280–1285.
   PubMed Web of Science ®Google Scholar
• Bronskill, S.E., Rochon, P.A., Gill, S.S., Herrmann, N., Hillmer, M.P., Bell, C.M., … Stukel, T.A. (2009). The relationship between variations in antipsychotic prescribing across nursing homes and short-term mortality, quality of care implications. Medical Care, 47, 1000–1008.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Briesacher, B.A., Field, T.S., Tjia, J., Lau, D.T., & Gurwitz, J.H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170, 89–95.
   PubMed Web of Science ®Google Scholar
• Cohen-Mansfield, J., & Billig, N. (1986). Agitated behaviors in the elderly, a conceptual review. Journal of the American Geriatrics Society, 34, 711–721.
   PubMed Web of Science ®Google Scholar
• de Jonghe, J.F., & Kat, M.G. (1996). Factor structure and validity of the Dutch version of the Cohen-Mansfield Agitation Inventory (CMAI-D). Journal of the American Geriatrics Society, 44, 888–889.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
   Google Scholar
• Edvardsson, D., Sandman, P.O., Nay, R., & Karlsson, S. (2008). Associations between the working characteristics of nursing staff and the prevalence of behavioral symptoms in people with dementia in residential care. International Psychogeriatrics, 20, 764–776.
   PubMed Web of Science ®Google Scholar
• Feng, Z., Hirdes, J.P., Smith, T.F., Finne-Soveri, H., Chi, I., Du Pasquier, J.N., … Mor, V. (2009). Use of physical restraints and antipsychotic medications in nursing homes: A cross-national study. International Journal of Geriatric Psychiatry, 24, 1110–1118.
   PubMed Web of Science ®Google Scholar
• Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). ‘Mini-mental state’: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
   PubMed Web of Science ®Google Scholar
• Fossey, J., Ballard, C., Juszczak, E., James, I., Alder, N., Jacoby, R., & Howard, R. (2006). Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia, cluster randomised trial. British Medical Journal, 332, 756–761.
   PubMed Web of Science ®Google Scholar
• Hughes, C.M., Lapane, K., Watson, M.C., & Davies, H.T. (2007). Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs & Aging, 24, 81–93.
   PubMed Web of Science ®Google Scholar
• Kleijer, B.C., van Marum, R.J., Egberts, A.C., Jansen, P.A., Frijters, D., Heerdink, E.R., & Ribbe, M. (2009). The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics. International Psychogeriatrics, 21, 931–940.
   PubMed Web of Science ®Google Scholar
• Koopmans, R.T. (2007). Are psychotropic drugs too frequently prescribed in Dutch nursing homes? Tijdschrift Voor Gerontologie en Geriatrie, 38, 270–273.
   PubMedGoogle Scholar
• Lanctot, K.L., Best, T.S., Mittmann, N., Liu, B.A., Oh, P.I., Einarson, T.R., & Naranjo, C.A. (1998). Efficacy and safety of neuroleptics in behavioural disorders associated with dementia. The Journal of Clinical Psychiatry, 59, 550–561.
   PubMed Web of Science ®Google Scholar
• Lindesay, J., Matthews, R., & Jagger, C. (2003). Factors associated with antipsychotic drug use in residential care: Changes between 1990 and 1997. International Journal of Geriatric Psychiatry, 18, 511–519.
   PubMed Web of Science ®Google Scholar
• McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.
   PubMed Web of Science ®Google Scholar
• Nijk, R.M., Zuidema, S.U., & Koopmans, R.T. (2009). Prevalence and correlates of psychotropicdrug use in Dutchnursing-homepatients with dementia. International Psychogeriatrics, 21, 485–493.
   PubMed Web of Science ®Google Scholar
• Nordic Council on Medicines. (1990). Guideline for ATC classification. Oslo: WHO collaborating for Drugs Statistics Methodology.
   Google Scholar
• Nederlandse Vereniging voor Klinische Geriatrie. (2005). Guideline diagnosis and pharmaceutical treatment of dementia.
   Google Scholar
• Nederlandse Vereniging van Verpleeghuisartsen. (2008). Guideline problem behaviour.
   Google Scholar
• Reisberg, B., Ferris, S., de Leon, M., & Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. The American Journal of Psychiatry, 139, 1136–1139.
   PubMed Web of Science ®Google Scholar
• Rochon, P.A., Stukel, T.A., Bronskill, S.E., Gomes, T., Sykora, K., Wodchis, W.P., & Anderson, G.M. (2007). Variation in nursing home antipsychotic prescribing rates. Archives of Internal Medicine, 167, 676–683.
   PubMed Web of Science ®Google Scholar
• Román, G.C., Tatemichi, T.K., Erkinjuntti, T., Cummings, J.L., Masdeu, J.C., Garcia, J.H., … Hofman, A. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250–260.
   PubMed Web of Science ®Google Scholar
• Ruths, S., Straand, J., & Nygaard, H.A. (2001). Psychotropic drug use in nursing homes – diagnostic indications and variations between institutions. European Journal of Clinical Pharmacology, 57, 523–528.
   PubMed Web of Science ®Google Scholar
• Schneider, L.S., Pollock, V.E., & Lyness, S.A. (1990). A meta-analysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatrics Society, 38, 553–563.
   PubMed Web of Science ®Google Scholar
• Snijders, T.A.B., & Bosker, R.J. (1999). Multilevel analysis. An introduction to basic and advanced multilevel modelling. London: Sage.
   Google Scholar
• Uchida, H., Mamo, D.C., Mulsant, B.H., Pollock, B.G., & Kapur, S. (2009). Increased antipsychotic sensitivity in elderly patients: Evidence and mechanisms. The Journal of Clinical Psychiatry, 70, 397–405.
   PubMed Web of Science ®Google Scholar
• van Gool, W.A., Stam, C.J., Steenhoek, A., & Hagemeijer, A. (2006). The practice guideline ‘Diagnosis and pharmaceutical treatment of dementia’. Nederlands tijdschrift voor geneeskunde, 150, 839–843.
   PubMedGoogle Scholar
• van Iersel, B.M., Zuidema, S.U., Koopmans, R.T.C.M., Verhey, F.R.J., & Olde Rikkert, M.G.M. (2005). Antipsychotics for behavioural and psychological problems in elderly people with dementia, a systematic review of adverse events. Drugs & Aging, 22, 845–858.
   PubMed Web of Science ®Google Scholar
• van Reekum, R., Clarke, D., Conn, D., Herrmann, N., Eryavec, G., Cohen, T., & Ostrander, L. (2002). A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. International Psychogeriatrics, 14, 197–210.
   PubMed Web of Science ®Google Scholar
• Wetzels, R.B., Zuidema, S.U., de Jonghe J.F., Verhey F.R., & Koopmans, R.T. (2010). Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. The American Journal of Geriatric Psychiatry, 18, 1054–1065.
   PubMed Web of Science ®Google Scholar
• Wetzels, R.B., Zuidema, S.U., de Jonghe J.F., Verhey F.R., & Koopmans, R.T. (2011). Prescribing pattern of psychotropic drugs in nursing homes residents with dementia. International Psychogeriatrics, 23, 1249–1259.
   PubMed Web of Science ®Google Scholar
• Zuidema, S.U., de Jonghe, J.F., Verhey, F.R., & Koopmans, R.T. (2007). Agitation in Dutch institutionalized patients with dementia: Factor analysis of the Dutch version of the Cohen-Mansfield Agitation Inventory. Dementia and Geriatric Cognitive Disorders, 23, 35–41.
   PubMed Web of Science ®Google Scholar
• Zuidema, S.U., de Jonghe, J.F., Verhey, F.R., & Koopmans, R.T.. (2010). Environmental correlates of neuropsychiatric symptoms in nursing home patients with dementia. International Journal of Geriatric Psychiatry, 25, 14–22.
   PubMed Web of Science ®Google Scholar
• Zuidema, S.U., de Jonghe, J.F., Verhey, F.R.J., & Koopmans, R.T. (2011). Psychotropic drug prescription in nursing home patients with dementia: Influence of environmental correlates and staff distress on physicians’ prescription behaviour. International Psychogeriatrics, 23, 1632–1639.
   PubMed Web of Science ®Google Scholar
• Zuidema, S.U., van Iersel, M.B., Koopmans, R.T., Verhey, F.R., Olde Rikkert, M.G. (2006). Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: A systematic review. Nederlands tijdschrift voor geneeskunde, 150, 1565–1573.
   PubMedGoogle Scholar